Biopharma Business

Tag "Janssen Biotech"

Janssen announces FDA approval of Stelara for plaque psoriasis

    Janssen announces FDA approval of Stelara for plaque psoriasis

The FDA has approved an expanded indication for Stelara for the treatment of adolescents with moderate plaque psoriasis. Janssen Biotech, Inc., has announced that the U.S. Food and Drug Administration

Read Full Article

Upcoming Events

[eventlist]

The Magazine

New Subscriber

Subscribe Here



Advertisements